Antiviral efficacy of lobucavir (BMS-180194), a cyclobutyl-guanosine nucleoside analogue, in the woodchuck (Marmota monax) model of chronic hepatitis B virus (HBV) infection

Antiviral Research

Volumn 48, Issue 3, 2000, Pages 197-203

  Genovesi, E V ^a   Lamb, L ^a   Medina, I ^a   Taylor, D ^a   Seifer, M ^a   Innaimo, S ^a   Colonno, R J ^a   Clark, J M ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

Carbocyclic guanosine nucleoside analogues; Chronic virus infection; Hepatitis B virus (HBV); Lobucavir; Woodchuck hepatitis virus (WHV); Woodchucks (Marmota monax)

Indexed keywords

ANTIVIRUS AGENT; DNA DIRECTED DNA POLYMERASE ALPHA; DOUBLE STRANDED DNA; LOBUCAVIR;

ANIMAL TISSUE; ARTICLE; DNA VIRUS; ENZYME ACTIVITY; GENOME; HEPADNAVIRUS; HEPATITIS B VIRUS; INFECTION; INFECTION RISK; NONHUMAN; PRIORITY JOURNAL; VIREMIA; VIRUS INFECTION; WOODCHUCK;

ANIMALS; DISEASE MODELS, ANIMAL; DNA, VIRAL; GUANINE; HEPATITIS B VIRUS, WOODCHUCK; HEPATITIS B, CHRONIC; HUMANS; MARMOTA; REVERSE TRANSCRIPTASE INHIBITORS; VIREMIA;

ANIMALIA; HEPATITIS B VIRUS; MARMOTA MONAX; WOODCHUCK HEPATITIS B VIRUS;

EID: 0034491961     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(00)00128-5     Document Type: Article

References (36)

1. Evaluation of SQ34514: Pharmacokinetics and efficiency in experimental herpes virus infections in mice
2. The identification and development of antiviral agents for the treatment of chronic hepatitis B virus infection
3. In vivo anti-viral activity and pharmacokinetics of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathio-lan-5-yl] cytosine in woodchuck hepatitis virus-infected woodchucks
4. Conjugation of adenine arabinoside 5′-monophosphate to arabinogalactan: Synthesis, characterization, and antiviral activity
5. (±)-(1α,2β,3α)-9-amino-[2,3-bis(hydroxymethyl)]-gu anine [(±)-BHCG or SQ33,054]: A potent and selective inhibitor of herpes viruses
6. Inhibition of woodchuck hepatitis virus replication by adenine arabinoside monophosphate coupled to lactosaminated poly-L-lysine and administered by intramuscular route
7. Inhibitory effects of 2′-fluorinated arabinosyl-pyrimidine nucleosides on woodchuck hepatitis virus replication in chronically infected woodchucks
8. Efficacy of the carbocyclic 2′-deoxyguanosine nucleoside BMS-200475 in the woodchuck model of hepatitis B virus infection
9. Taxonomic classification of human hepatitis B virus
10. Comparison of properities of woodchuck hepatitis virus and human hepatitis B virus endogenous DNA polymerases
11. The treatment of chronic viral hepatitis
12. Antiviral activities of oral 1-O-hexadecylpropanediol-3-phosphoacyclovir and acyclovir in woodchucks with chronic woodchuck hepatitis virus infection
13. Efficiency of oxetanocin-G, a novel nucleoside against the woodchuck hepatitis virus
14. Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus
15. Use of a standardized cell culture assay to assess activities of nucleoside analogs against hepatitis B virus replication
16. Effect of oral administration of emtricitabine on woodchuck hepatitis virus replication in chronically infected woodchucks
17. Hepatitis B: New approaches for antiviral chemotherapy
18. Chronic hepatitis B virus infection: Treatment strategies for the next millennium
19. Hepatitis B: Evolving epidemiology and implications for control
20. The problem of antiviral therapy for chronic hepadnavirus infection
21. Larnivudine therapy of WHV-infected woodchucks
22. Hepatitis B viral DNA-RNA hybrid molecules in particles from infected liver are converted to viral DNA molecules during an endogenous DNA polymerase reaction
23. Hepatitis B virus morphogenesis
24. Adenine arabinoside monophosphate and acyclovir monophosphate coupled to lactosaminated albumin reduce woodchuck hepatitis virus viremia at doses lower than do the unconjugated drugs
25. The woodchuck: An animal model for hepatitis B virus infection in man
26. Animal hepatitis B viruses
27. Viral DNA synthesis
28. In vitro inhibition of hepadnavirus polymerases by the triphosphates of BMS-200475 and lobucavir
29. Heterogeneous response for mammalian hepadnavirus infection to acyclovir: Drug arrested intermediates of minus strand viral DNA are enveloped and secreted from infected cells as virion-like particles
30. Woodchuck hepadnaviruses
31. Animal models in the preclinical assessment of therapy for viral hepatitis
32. Antiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infection
33. Antiviral activity of lobucavir in the woodchuck model of hepatitis B virus infection: 12-week oral dosing study in adult woodchucks with chronic woodchuck hepatitis virus infection
34. Metabolic studies on BMS-200475, a new antiviral compound active against hepatitis B virus
35. Efficacy of BMS-180194 against experimental cytomegalovirus infections in immunocompromised mice
36. Therapy of chronic hepatitis B: Virus infection: Inhibition of the viral polymerase and other antiviral strategies